The main considerations in the interdisciplinary care of patients with Sjögren's disease are measures to improve quality of life, pharmacological and non-pharmacological treatments to keep disease activity in check, and management of the risk of lymphoma. Future therapeutic approaches must take the heterogeneity of the disease into account.
Ü bersichtsarbeit 226 Tomiak C, Theander E. M ü digkeit beim Sj ö gren-Syndrom -Therapeutischer … Akt Rheumatol 2010; 35: 226 -235 Bibliografi e DOI http://dx.Schl ü sselw ö rter • ▶ Sj ö gren-Syndrom • ▶ M ü digkeit • ▶ Pathophysiologie der M ü digkeit • ▶ Therapie der M ü digkeit
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.